Shaoli Lin, Ph.D.
- Center for Cancer Research
- National Cancer Institute
RESEARCH SUMMARY
Shaoli earned her Ph.D. degree in Comparative Biomedical Science from the University of Maryland, College Park. Her current research focuses on the roles of GPC3 and mesothelin in connection to Wnt/Yap signaling in cancer cells and uses antibody engineering to generate CAR T cell therapy.
Areas of Expertise
antibody engineering